Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION

Filed by CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 13, 2026
Income
$10,000.00
Expenses
Not reported
Filing UUID
bd913d73-2ea0-4e3f-a799-c072525d14cb
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

Hereditary Hemorrhagic Telanglectasia (HHT)

HCR · Health Issues

HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); HR 5304/S 2587, FY26 Labor HHS Education Appropriations Act, National HHT Center of Excellence Program

Literal federal measure citations: HR 4016, S 2572, HR 5304, S 2587

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.